Avanir Shareholders Can't Halt Proxy Vote

Law360, Los Angeles (February 12, 2014, 9:36 PM EST) -- A California federal judge on Wednesday allowed Avanir Pharmaceuticals Inc.'s shareholder vote on issues like executive pay to proceed despite the objections of a putative class of investors claiming that its proxy notice was misleading, ruling all the information required for an informed vote was in the notice. 

U.S. District Judge Cormac J. Carney denied the plaintiffs' motion for a preliminary injunction to stop the vote, which included a proposal to issue 17 million shares to be used for equity-based compensation. Avanir had claimed it was...
To view the full article, register now.




Case Information

Case Title

Robert Masters v. Avanir Pharmaceuticals Inc. et al

Case Number



California Central

Nature of Suit



Cormac J. Carney

Date Filed

January 13, 2014

Law Firms


Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.